FULLER H B CO — Form 8-K
Filed October 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
H.B. Fuller Company issued $850 million in aggregate principal amount of 7.625% Notes due October 15, 2034, dated October 21, 2026, through a Third Supplemental Indenture with U.S. Bank Trust Company as Trustee. The notes are senior unsecured debt, initially offered via Rule 144A and Regulation S. Notably, $450 million of the notes (52.9% of the issuance) are subject to mandatory redemption at par plus accrued interest if the proposed acquisition of Advanced Medical Solutions Group plc is not completed by June 25, 2027 (extendable to October 21, 2027). Interest payable semi-annually on April 15 and October 15 commencing April 15, 2027.
Why this rating
Routine debt issuance (~28% of market cap) to fund AMS acquisition; $450M contingent redemption adds execution risk but does not alter current financial profile materially.
See more from October 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.